Optimind Pharma Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 0/6
Optimind Pharma has a total shareholder equity of CA$-39.1K and total debt of CA$125.6K, which brings its debt-to-equity ratio to -321.5%. Its total assets and total liabilities are CA$219.2K and CA$258.3K respectively.
Anahtar bilgiler
-321.5%
Borç/özkaynak oranı
CA$125.64k
Borç
| Faiz karşılama oranı | n/a |
| Nakit | CA$90.41k |
| Eşitlik | -CA$39.08k |
| Toplam yükümlülükler | CA$258.25k |
| Toplam varlıklar | CA$219.17k |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: OMND has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Uzun Vadeli Yükümlülükler: OMND has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: OMND has negative shareholder equity, which is a more serious situation than a high debt level.
Borcun Azaltılması: OMND's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: OMND has less than a year of cash runway based on its current free cash flow.
Tahmini Nakit Akışı: OMND has less than a year of cash runway if free cash flow continues to grow at historical rates of 23.2% each year.